Biosimilars have the potential to change the way we think about, identify, and manage health problems. They are already impacting both clinical research and patient care, and this impact will only grow as our understanding and technologies improve. Written by a team of experienced specialists in clinical development, this book discusses various potential drug development strategies, the design and analysis of pharmacokinetics (PK) studies, and the design and analysis of efficacy studies.
Dieses Ebook kaufen – und ein weitere GRATIS erhalten!
Format EPUB ● Seiten 268 ● ISBN 9781315355900 ● Herausgeber Kerry B. (Pfizer, Cambridge, Massachusetts, USA) Barker & Sr., Ralph B. (Boston University, Massachusetts, USA) D’Agostino ● Verlag CRC Press ● Erscheinungsjahr 2016 ● herunterladbar 3 mal ● Währung EUR ● ID 5021283 ● Kopierschutz Adobe DRM
erfordert DRM-fähige Lesetechnologie